US67066V1017

Taking everything into account, **NAD** scores **3** out of 10 in our fundamental rating. **NAD** was compared to 0 industry peers in the **Unkown** industry. While **NAD** seems to be doing ok healthwise, there are quite some concerns on its profitability. **NAD** is valued expensive and it does not seem to be growing.

In the past year **NAD** was profitable.

In the past year **NAD** had a positive cash flow from operations.

In multiple years **NAD** reported negative net income over the last 5 years.

Of the past 5 years **NAD** 4 years had a positive operating cash flow.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.04% | ||

ROE | 0.04% | ||

ROIC | 2.02% |

ROA(3y)-3.65%

ROA(5y)-0.75%

ROE(3y)-3.96%

ROE(5y)-0.91%

ROIC(3y)2.27%

ROIC(5y)2.24%

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 58.4% | ||

PM (TTM) | 0.95% | ||

GM | 58.58% |

OM growth 3Y2.44%

OM growth 5Y-0.71%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y2.43%

GM growth 5Y-0.74%

Compared to 1 year ago, **NAD** has about the same amount of shares outstanding.

An Altman-Z score of **12.45** indicates that **NAD** is not in any danger for bankruptcy at the moment.

The Debt to FCF ratio of **NAD** is **0.32**, which is an excellent value as it means it would take **NAD**, only **0.32** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **0.02** indicates that **NAD** is not too dependend on debt financing.

Even though the debt/equity ratio score it not favorable for **NAD**, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.02 | ||

Debt/FCF | 0.32 | ||

Altman-Z | 12.45 |

ROIC/WACCN/A

WACCN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.73 | ||

Quick Ratio | 2.73 |

Measured over the past years, **NAD** shows a small growth in **Revenue**. The Revenue has been growing by **0.73%** on average per year.

EPS 1Y (TTM)100.51%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q172.95%

Revenue 1Y (TTM)2.41%

Revenue growth 3Y0.85%

Revenue growth 5Y0.73%

Revenue growth Q2Q5.59%

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

The **Price/Earnings** ratio is **1114.00**, which means the current valuation is very expensive for **NAD**.

Compared to an average S&P500 **Price/Earnings** ratio of **24.54**, **NAD** is valued quite expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 1114 | ||

Fwd PE | N/A |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 9.15 | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.88% |

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

DP6638.1%

EPS Next 2YN/A

EPS Next 3YN/A

**NUVEEN QUAL MUNI INCOME FD**

NYSE:NAD (12/11/2023, 3:10:03 PM)

After market: 11.14 0 (0%)**11.14**

**-0.02 (-0.18%) **

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.60B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 3.88% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 1114 | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.04% | ||

ROE | 0.04% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 58.4% | ||

PM (TTM) | 0.95% | ||

GM | 58.58% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.04

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.02 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.73 | ||

Quick Ratio | 2.73 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)100.51%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)2.41%

Revenue growth 3Y0.85%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y